90 related articles for article (PubMed ID: 12642698)
21. Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells.
Sengupta S; Vonesch JL; Waltzinger C; Zheng H; Wasylyk B
EMBO J; 2000 Nov; 19(22):6051-64. PubMed ID: 11080152
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1.
Huang SM; Schönthal AH; Stallcup MR
Oncogene; 2001 Apr; 20(17):2134-43. PubMed ID: 11360197
[TBL] [Abstract][Full Text] [Related]
23. p53 pathway in renal cell carcinoma is repressed by a dominant mechanism.
Gurova KV; Hill JE; Razorenova OV; Chumakov PM; Gudkov AV
Cancer Res; 2004 Mar; 64(6):1951-8. PubMed ID: 15026329
[TBL] [Abstract][Full Text] [Related]
24. p53 and apoptosis: it's not just in the nucleus anymore.
Manfredi JJ
Mol Cell; 2003 Mar; 11(3):552-4. PubMed ID: 12667439
[TBL] [Abstract][Full Text] [Related]
25. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
26. The positive regulation of p53 by the tumor suppressor VHL.
Roe JS; Youn HD
Cell Cycle; 2006 Sep; 5(18):2054-6. PubMed ID: 16969113
[TBL] [Abstract][Full Text] [Related]
27. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
Boyd SD; Tsai KY; Jacks T
Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695
[TBL] [Abstract][Full Text] [Related]
28. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.
D'Orazi G; Cecchinelli B; Bruno T; Manni I; Higashimoto Y; Saito S; Gostissa M; Coen S; Marchetti A; Del Sal G; Piaggio G; Fanciulli M; Appella E; Soddu S
Nat Cell Biol; 2002 Jan; 4(1):11-9. PubMed ID: 11780126
[TBL] [Abstract][Full Text] [Related]
29. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
Zeng PY; Berger SL
Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
[TBL] [Abstract][Full Text] [Related]
30. Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc epsilon RI-mediated mast cell activation.
Kyo S; Sada K; Qu X; Maeno K; Miah SM; Kawauchi-Kamata K; Yamamura H
Genes Cells; 2003 Oct; 8(10):825-36. PubMed ID: 14531861
[TBL] [Abstract][Full Text] [Related]
31. The oncoprotein SS18-SSX1 promotes p53 ubiquitination and degradation by enhancing HDM2 stability.
D'Arcy P; Maruwge W; Ryan BA; Brodin B
Mol Cancer Res; 2008 Jan; 6(1):127-38. PubMed ID: 18234968
[TBL] [Abstract][Full Text] [Related]
32. Failure of viral oncoproteins to target the p53-homologue p51A.
Roth J; Dobbelstein M
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3251-3255. PubMed ID: 10567658
[TBL] [Abstract][Full Text] [Related]
33. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
34. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.
Hofmann TG; Möller A; Sirma H; Zentgraf H; Taya Y; Dröge W; Will H; Schmitz ML
Nat Cell Biol; 2002 Jan; 4(1):1-10. PubMed ID: 11740489
[TBL] [Abstract][Full Text] [Related]
35. Regulation of p53 function.
Woods DB; Vousden KH
Exp Cell Res; 2001 Mar; 264(1):56-66. PubMed ID: 11237523
[No Abstract] [Full Text] [Related]
36. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53.
Hoppe-Seyler F; Butz K
J Virol; 1993 Jun; 67(6):3111-7. PubMed ID: 8388491
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
Mao L; Deng WW; Yu GT; Bu LL; Liu JF; Ma SR; Wu L; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2017 Mar; 140(5):1173-1185. PubMed ID: 27798955
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-delta with Src family kinases in the RBL-2H3 mast cell line: regulation of Src family kinase activity by protein kinase C-delta.
Song JS; Swann PG; Szallasi Z; Blank U; Blumberg PM; Rivera J
Oncogene; 1998 Jul; 16(26):3357-68. PubMed ID: 9692543
[TBL] [Abstract][Full Text] [Related]
39. Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein.
Eichten A; Westfall M; Pietenpol JA; Münger K
Virology; 2002 Mar; 295(1):74-85. PubMed ID: 12033767
[TBL] [Abstract][Full Text] [Related]
40. C
Fekry B; Jeffries KA; Esmaeilniakooshkghazi A; Szulc ZM; Knagge KJ; Kirchner DR; Horita DA; Krupenko SA; Krupenko NI
Nat Commun; 2018 Oct; 9(1):4149. PubMed ID: 30297838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
